UK markets closed

Applied DNA Sciences, Inc. (APDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4100-0.0180 (-4.21%)
At close: 04:00PM EDT
0.4200 +0.01 (+2.44%)
After hours: 05:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.27M
Enterprise value 5.03M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.63
Price/book (mrq)1.72
Enterprise value/revenue 0.56
Enterprise value/EBITDA -0.41

Trading information

Stock price history

Beta (5Y monthly) 0.10
52-week change 3-62.61%
S&P500 52-week change 329.57%
52-week high 31.8600
52-week low 30.3700
50-day moving average 30.5654
200-day moving average 30.9785

Share statistics

Avg vol (3-month) 3107.67k
Avg vol (10-day) 3258.46k
Shares outstanding 516.98M
Implied shares outstanding 616.98M
Float 813.6M
% held by insiders 112.32%
% held by institutions 119.23%
Shares short (15 Mar 2024) 4261.21k
Short ratio (15 Mar 2024) 41.81
Short % of float (15 Mar 2024) 41.92%
Short % of shares outstanding (15 Mar 2024) 41.54%
Shares short (prior month 15 Feb 2024) 4272.68k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 301 Nov 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -80.13%
Operating margin (ttm)-425.18%

Management effectiveness

Return on assets (ttm)-55.96%
Return on equity (ttm)-110.02%

Income statement

Revenue (ttm)9M
Revenue per share (ttm)0.68
Quarterly revenue growth (yoy)-83.10%
Gross profit (ttm)N/A
EBITDA -12.2M
Net income avi to common (ttm)-7.29M
Diluted EPS (ttm)-0.5500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.36M
Total cash per share (mrq)0.2
Total debt (mrq)1.12M
Total debt/equity (mrq)27.06%
Current ratio (mrq)1.77
Book value per share (mrq)0.31

Cash flow statement

Operating cash flow (ttm)-7.59M
Levered free cash flow (ttm)-4.02M